Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Yang, Boyu [1 ]
Wu, Shaowen [1 ]
Yu, Shanshan [1 ]
Liang, Xiaoling [1 ]
Liu, Qifa [2 ]
Huang, Fen [2 ]
Liang, Lingyi [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangdong Prov Clin Res Ctr Ocular Dis,State Key, Guangdong Prov Key Lab Ophthalmol & Visual Sci, Guangzhou, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
BONE-MARROW-TRANSPLANTATION; VISUAL-EVOKED POTENTIALS; VERSUS-HOST-DISEASE; CYTOMEGALOVIRUS RETINITIS; OCULAR FINDINGS; SOLID-ORGAN; EYE;
D O I
10.1038/s41433-022-02250-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To study the posterior segment complications (PSC) and the risk factors in patients after allogeneic hematopoietic stem cell transplantation (HSCT). Methods This cross-sectional, case-control study enroled 143 patients who received allogeneic HSCT. Comprehensive ocular examinations were performed to evaluate PSC and ocular Graft-versus-Host Disease (oGVHD). PSC was diagnosed based on the characteristic fundus findings and auxiliary examinations. Visual-evoked potential was examined in patients with unexplained visual loss and suspected visual pathway pathology (VPP). Ocular surface disease index, corneal fluorescein staining, conjunctival injection and Schirmer's test were scored to diagnose oGVHD. Results PSC was detected in 36 (25.2%) patients, while 107 (74.8%) patients were not. Among them, 102 (71.3%) patients were diagnosed with oGVHD. The most common PSC included cytomegalovirus retinitis (13/143, 9.1%) and VPP (7/143, 4.9%). Central nervous system relapse of leukaemia was detected in four out of seven cases of VPP. Patients with PSC had worse visual acuity, lower prevalence and milder severity of oGVHD, and more donors from unrelated and human leucocyte antigen (HLA)-mismatch (all P < 0.05). PSC was associated with transplant from unrelated (OR = 6.494, 95% CI: 1.635-25.794, P = 0.008) and HLA-mismatched (OR = 7.193, 95% CI: 2.829-18.291, P < 0.001) donor but not with the occurrence of systemic GVHD or oGVHD. Conclusions PSC in post-HSCT patients was more common than previously noted, deserving the concern of ophthalmologists, especially in patients with unrelated or HLA-mismatched donors.
引用
收藏
页码:1816 / 1821
页数:6
相关论文
共 50 条
  • [1] POSTERIOR EYE SEGMENT COMPLICATIONS RELATED TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Yoo, Young-Sik
    Na, Kyung-Sun
    Shin, Jeong Ah
    Park, Young-Hoon
    Lee, Jong Wook
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (01): : 135 - 143
  • [2] INFECTIOUS COMPLICATIONS AND THEIR CONTRIBUTING RISK FACTORS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Akhmedov, M., I
    Klyasova, G. A.
    Parovichnikova, E. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (01): : 90 - 107
  • [3] Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact
    Dowling, M. R.
    Li, S.
    Dey, B. R.
    McAfee, S. L.
    Hock, H. R.
    Spitzer, T. R.
    Chen, Y-B
    Ballen, K. K.
    BONE MARROW TRANSPLANTATION, 2018, 53 (02) : 199 - 206
  • [4] Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation
    Maffini, Enrico
    Festuccia, Moreno
    Brunello, Lucia
    Boccadoro, Mario
    Giaccone, Luisa
    Bruno, Benedetto
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : 388 - 397
  • [5] Complications of Allogeneic Hematopoietic Stem Cell Transplantation
    Arnaout, Karim
    Patel, Nihar
    Jain, Maneesh
    El-Amm, Joelle
    Amro, Farah
    Tabbara, Imad A.
    CANCER INVESTIGATION, 2014, 32 (07) : 349 - 362
  • [6] Risk Factors of Cytomegalovirus Retinitis Occurrence After Allogeneic Hematopoietic Stem Cell Transplantation
    Zhang, Hai-Qing
    Feng, Jing-Hong
    Li, Sheng-Jun
    Yang, Yun-Xian
    Long, Yan
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2025, 33 (02) : 295 - 302
  • [7] Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation
    Na, K-S
    Yoo, Y-S
    Mok, J. W.
    Lee, J. W.
    Joo, C-K
    BONE MARROW TRANSPLANTATION, 2015, 50 (11) : 1459 - 1464
  • [8] Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
    Onizuka, Makoto
    Fujii, Nobuharu
    Nakasone, Hideki
    Ogata, Masao
    Atsuta, Yoshiko
    Suzuki, Ritsuro
    Uchida, Naoyuki
    Ohashi, Kazuteru
    Ozawa, Yukiyasu
    Eto, Tetsuya
    Ikegame, Kazuhiro
    Nakamae, Hirohisa
    Inoue, Masami
    Fukuda, Takahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 534 - 544
  • [9] Central nervous system complications after allogeneic hematopoietic stem cell transplantation
    Chaudhary, Ranjit Kumar
    Dhakal, Prajwal
    Aryal, Aashrayata
    Bhatt, Vijaya Raj
    FUTURE ONCOLOGY, 2017, 13 (25) : 2297 - 2312
  • [10] Lethal Pulmonary Complications After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
    Fazekas, Tamas
    Attarbaschi, Andishe
    Lawitschka, Anita
    Seidel, Markus
    Poetschger, Ulrike
    Peters, Christina
    Mann, Georg
    Gadner, Helmut
    Matthes-Martin, Susanne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (02) : 115 - 119